Form 4: P3 Health Partners Insider Buys $4.99 Million in Units

Sentiment:

SEC Form 4


Leavitt Equity Partners III, L.P. purchased 7,974,481 units of P3 Health Partners Inc. at $0.6270 per unit, consisting of one share of Class A Common Stock and one warrant.

Summary

  • Leavitt Equity Partners III, L.P. acquired 7,974,481 units of P3 Health Partners Inc. on May 24, 2024.
  • The purchase price was $0.6270 per unit.
  • Each unit consists of one share of Class A Common Stock and one warrant to purchase one share of Class A Common Stock.
  • The warrants have an exercise price of $0.502 and expire on May 24, 2031.
  • Following the transaction, Leavitt Equity Partners III, L.P. beneficially owns 16,919,024 shares of Class A Common Stock indirectly.
  • Leavitt Equity Partners II, L.P. beneficially owns 894,454 shares of Class A Common Stock indirectly.
  • Leavitt Equity Partners III, L.P. also beneficially owns 7,974,481 warrants indirectly.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive due to insider buying, which suggests confidence, but it's a routine transaction disclosure.

Positives

  • Insider buying can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

This transaction reflects investment activity within the healthcare services sector, specifically companies involved in population health management and value-based care models.

Comparison to Industry Standards

  • It's difficult to compare this specific transaction to industry standards without knowing the specific investment strategies of Leavitt Equity Partners.
  • However, insider buying is generally viewed positively, especially when compared to insider selling.
  • Similar transactions in the healthcare sector often involve strategic investments in companies with growth potential in value-based care.

Stakeholder Impact

  • The transaction could have a slightly positive impact on shareholders due to the signal of confidence from a major shareholder.
  • The transaction has no immediate impact on employees, customers, suppliers, or creditors.

Key Dates

DateDescription
05/24/2024Date of transaction: purchase of units and warrants.
05/24/2031Expiration date of the warrants.
06/26/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.